Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 10 studies | 35% ± 16% | |
glutamatergic neuron | 5 studies | 46% ± 19% | |
oligodendrocyte precursor cell | 5 studies | 33% ± 9% | |
endothelial cell | 4 studies | 26% ± 9% | |
epithelial cell | 4 studies | 23% ± 3% | |
GABAergic neuron | 3 studies | 52% ± 9% | |
ependymal cell | 3 studies | 32% ± 14% | |
goblet cell | 3 studies | 19% ± 1% | |
interneuron | 3 studies | 50% ± 21% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 33% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2096.50 | 245 / 245 | 100% | 14.69 | 502 / 502 |
intestine | 100% | 2752.42 | 966 / 966 | 99% | 21.57 | 523 / 527 |
brain | 99% | 1776.22 | 2621 / 2642 | 100% | 19.17 | 704 / 705 |
stomach | 100% | 1284.69 | 359 / 359 | 99% | 22.94 | 283 / 286 |
esophagus | 100% | 1851.77 | 1445 / 1445 | 99% | 21.44 | 181 / 183 |
pancreas | 100% | 824.38 | 327 / 328 | 98% | 12.34 | 175 / 178 |
kidney | 100% | 1074.91 | 89 / 89 | 98% | 13.86 | 879 / 901 |
uterus | 100% | 1508.24 | 170 / 170 | 97% | 15.32 | 443 / 459 |
lung | 100% | 1669.78 | 577 / 578 | 95% | 12.38 | 1094 / 1155 |
thymus | 100% | 1363.36 | 652 / 653 | 94% | 8.88 | 571 / 605 |
ovary | 100% | 1203.31 | 180 / 180 | 94% | 9.72 | 405 / 430 |
breast | 100% | 1248.50 | 459 / 459 | 93% | 12.76 | 1036 / 1118 |
adrenal gland | 100% | 1747.84 | 258 / 258 | 92% | 7.67 | 212 / 230 |
skin | 100% | 1103.50 | 1800 / 1809 | 89% | 12.20 | 420 / 472 |
bladder | 100% | 1470.43 | 21 / 21 | 86% | 11.93 | 431 / 504 |
muscle | 100% | 1538.43 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 898.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.13 | 1 / 1 |
adipose | 100% | 1079.83 | 1199 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1920.38 | 1325 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1592.26 | 843 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 76% | 5.05 | 61 / 80 |
liver | 5% | 21.95 | 12 / 226 | 41% | 4.12 | 168 / 406 |
lymph node | 0% | 0 | 0 / 0 | 38% | 2.26 | 11 / 29 |
peripheral blood | 5% | 32.78 | 45 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
Gene name | RAVER2 |
Protein name | Ribonucleoprotein PTB-binding 2 (Protein raver-2) Ribonucleoprotein, PTB binding 2 |
Synonyms | KIAA1579 |
Description | FUNCTION: May bind single-stranded nucleic acids. . |
Accessions | ENST00000418058.1 E9PE10 ENST00000371072.8 [Q9HCJ3-2] ENST00000294428.8 [Q9HCJ3-1] Q9HCJ3 |